261 related articles for article (PubMed ID: 29596874)
1. Controlling release from 3D printed medical devices using CLIP and drug-loaded liquid resins.
Bloomquist CJ; Mecham MB; Paradzinsky MD; Janusziewicz R; Warner SB; Luft JC; Mecham SJ; Wang AZ; DeSimone JM
J Control Release; 2018 May; 278():9-23. PubMed ID: 29596874
[TBL] [Abstract][Full Text] [Related]
2. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems.
Goyanes A; Det-Amornrat U; Wang J; Basit AW; Gaisford S
J Control Release; 2016 Jul; 234():41-8. PubMed ID: 27189134
[TBL] [Abstract][Full Text] [Related]
3. Controlled drug delivery from 3D printed two-photon polymerized poly(ethylene glycol) dimethacrylate devices.
Do AV; Worthington KS; Tucker BA; Salem AK
Int J Pharm; 2018 Dec; 552(1-2):217-224. PubMed ID: 30268853
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of drug-loaded hydrogels with stereolithographic 3D printing.
Martinez PR; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2017 Oct; 532(1):313-317. PubMed ID: 28888978
[TBL] [Abstract][Full Text] [Related]
5. Fabrication of an osmotic 3D printed solid dosage form for controlled release of active pharmaceutical ingredients.
Gioumouxouzis CI; Tzimtzimis E; Katsamenis OL; Dourou A; Markopoulou C; Bouropoulos N; Tzetzis D; Fatouros DG
Eur J Pharm Sci; 2020 Feb; 143():105176. PubMed ID: 31809907
[TBL] [Abstract][Full Text] [Related]
6. 3D printed UV light cured polydimethylsiloxane devices for drug delivery.
Holländer J; Hakala R; Suominen J; Moritz N; Yliruusi J; Sandler N
Int J Pharm; 2018 Jun; 544(2):433-442. PubMed ID: 29129573
[TBL] [Abstract][Full Text] [Related]
7. Continuous liquid interface production of 3D printed drug-loaded spacers to improve prostate cancer brachytherapy treatment.
Hagan CT; Bloomquist C; Kim I; Knape NM; Byrne JD; Tu L; Wagner K; Mecham S; DeSimone J; Wang AZ
Acta Biomater; 2022 Aug; 148():163-170. PubMed ID: 35724920
[TBL] [Abstract][Full Text] [Related]
8. Printed Drug-Delivery Systems for Improved Patient Treatment.
Sandler N; Preis M
Trends Pharmacol Sci; 2016 Dec; 37(12):1070-1080. PubMed ID: 27992318
[TBL] [Abstract][Full Text] [Related]
9. 3D printed drug delivery devices: perspectives and technical challenges.
Palo M; Holländer J; Suominen J; Yliruusi J; Sandler N
Expert Rev Med Devices; 2017 Sep; 14(9):685-696. PubMed ID: 28774216
[TBL] [Abstract][Full Text] [Related]
10. Three-dimensional printing of drug-eluting implants: preparation of an antimicrobial polylactide feedstock material.
Water JJ; Bohr A; Boetker J; Aho J; Sandler N; Nielsen HM; Rantanen J
J Pharm Sci; 2015 Mar; 104(3):1099-107. PubMed ID: 25640314
[TBL] [Abstract][Full Text] [Related]
11. 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release.
Kyobula M; Adedeji A; Alexander MR; Saleh E; Wildman R; Ashcroft I; Gellert PR; Roberts CJ
J Control Release; 2017 Sep; 261():207-215. PubMed ID: 28668378
[TBL] [Abstract][Full Text] [Related]
12. Digital light processing (DLP) 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets.
Kadry H; Wadnap S; Xu C; Ahsan F
Eur J Pharm Sci; 2019 Jul; 135():60-67. PubMed ID: 31108205
[TBL] [Abstract][Full Text] [Related]
13. A Proof of Concept for 3D Printing of Solid Lipid-Based Formulations of Poorly Water-Soluble Drugs to Control Formulation Dispersion Kinetics.
Vithani K; Goyanes A; Jannin V; Basit AW; Gaisford S; Boyd BJ
Pharm Res; 2019 May; 36(7):102. PubMed ID: 31098846
[TBL] [Abstract][Full Text] [Related]
14. 3D-Printed Network Structures as Controlled-Release Drug Delivery Systems: Dose Adjustment, API Release Analysis and Prediction.
Korte C; Quodbach J
AAPS PharmSciTech; 2018 Nov; 19(8):3333-3342. PubMed ID: 29855799
[TBL] [Abstract][Full Text] [Related]
15. Photocurable poly(ethylene glycol) as a bioink for the inkjet 3D pharming of hydrophobic drugs.
Acosta-Vélez GF; Zhu TZ; Linsley CS; Wu BM
Int J Pharm; 2018 Jul; 546(1-2):145-153. PubMed ID: 29705105
[TBL] [Abstract][Full Text] [Related]
16. Combination of 3D printing technologies and compressed tablets for preparation of riboflavin floating tablet-in-device (TiD) systems.
Fu J; Yin H; Yu X; Xie C; Jiang H; Jin Y; Sheng F
Int J Pharm; 2018 Oct; 549(1-2):370-379. PubMed ID: 30107218
[TBL] [Abstract][Full Text] [Related]
17. Ethylene vinyl acetate (EVA) as a new drug carrier for 3D printed medical drug delivery devices.
Genina N; Holländer J; Jukarainen H; Mäkilä E; Salonen J; Sandler N
Eur J Pharm Sci; 2016 Jul; 90():53-63. PubMed ID: 26545484
[TBL] [Abstract][Full Text] [Related]
18. Three-Dimensional (3D)-Printed Zero-Order Released Platform: a Novel Method of Personalized Dosage Form Design and Manufacturing.
Fang D; Yang Y; Cui M; Pan H; Wang L; Li P; Wu W; Qiao S; Pan W
AAPS PharmSciTech; 2021 Jan; 22(1):37. PubMed ID: 33409925
[TBL] [Abstract][Full Text] [Related]
19. Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets.
Zhang J; Feng X; Patil H; Tiwari RV; Repka MA
Int J Pharm; 2017 Mar; 519(1-2):186-197. PubMed ID: 28017768
[TBL] [Abstract][Full Text] [Related]
20. PLA/F68/dexamethasone implants prepared by hot-melt extrusion for controlled release of anti-inflammatory drug to implantable medical devices: I. Preparation, characterization and hydrolytic degradation study.
Li D; Guo G; Fan R; Liang J; Deng X; Luo F; Qian Z
Int J Pharm; 2013 Jan; 441(1-2):365-72. PubMed ID: 23178216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
